A citation-based method for searching scientific literature

Christine Timko, Nicole R Schultz, Michael A Cucciare, Lisa Vittorio, Christina Garrison-Diehn. J Addict Dis 2016
Times Cited: 213







List of co-cited articles
535 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Luis Sordo, Gregorio Barrio, Maria J Bravo, B Iciar Indave, Louisa Degenhardt, Lucas Wiessing, Marica Ferri, Roberto Pastor-Barriuso. BMJ 2017
809
39

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2014
864
20

Retention of patients in opioid substitution treatment: A systematic review.
Aisling Máire O'Connor, Gráinne Cousins, Louise Durand, Joe Barry, Fiona Boland. PLoS One 2020
69
26

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Marc R Larochelle, Dana Bernson, Thomas Land, Thomas J Stopka, Na Wang, Ziming Xuan, Sarah M Bagley, Jane M Liebschutz, Alexander Y Walley. Ann Intern Med 2018
448
17

Development of a Cascade of Care for responding to the opioid epidemic.
Arthur Robin Williams, Edward V Nunes, Adam Bisaga, Frances R Levin, Mark Olfson. Am J Drug Alcohol Abuse 2019
126
16

Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
Yih-Ing Hser, Andrew J Saxon, David Huang, Al Hasson, Christie Thomas, Maureen Hillhouse, Petra Jacobs, Cheryl Teruya, Paul McLaughlin, Katharina Wiest,[...]. Addiction 2014
244
15

Long-term retention in Office Based Opioid Treatment with buprenorphine.
Zoe M Weinstein, Hyunjoong W Kim, Debbie M Cheng, Emily Quinn, David Hui, Colleen T Labelle, Mari-Lynn Drainoni, Sara S Bachman, Jeffrey H Samet. J Subst Abuse Treat 2017
104
15

Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
Hillary Samples, Arthur Robin Williams, Mark Olfson, Stephen Crystal. J Subst Abuse Treat 2018
76
19

Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.
Sarah E Wakeman, Marc R Larochelle, Omid Ameli, Christine E Chaisson, Jeffrey Thomas McPheeters, William H Crown, Francisca Azocar, Darshak M Sanghavi. JAMA Netw Open 2020
238
13

Developing an opioid use disorder treatment cascade: A review of quality measures.
Arthur Robin Williams, Edward V Nunes, Adam Bisaga, Harold A Pincus, Kimberly A Johnson, Aimee N Campbell, Remien H Remien, Stephen Crystal, Peter D Friedmann, Frances R Levin,[...]. J Subst Abuse Treat 2018
83
15


Leaving buprenorphine treatment: patients' reasons for cessation of care.
Jan Gryczynski, Shannon Gwin Mitchell, Jerome H Jaffe, Kevin E O'Grady, Yngvild K Olsen, Robert P Schwartz. J Subst Abuse Treat 2014
71
15





Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Joshua D Lee, Edward V Nunes, Patricia Novo, Ken Bachrach, Genie L Bailey, Snehal Bhatt, Sarah Farkas, Marc Fishman, Phoebe Gauthier, Candace C Hodgkins,[...]. Lancet 2018
341
9

Medication-assisted therapies--tackling the opioid-overdose epidemic.
Nora D Volkow, Thomas R Frieden, Pamela S Hyde, Stephen S Cha. N Engl J Med 2014
639
9





Opioid agonist treatment for pharmaceutical opioid dependent people.
Suzanne Nielsen, Briony Larance, Louisa Degenhardt, Linda Gowing, Chyanne Kehler, Nicholas Lintzeris. Cochrane Database Syst Rev 2016
160
7

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, Marilyn Byrne, Hilary S Connery, William Dickinson, John Gardin, Margaret L Griffin, Marc N Gourevitch, Deborah L Haller,[...]. Arch Gen Psychiatry 2011
339
7

Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
Lawrence Scholl, Puja Seth, Mbabazi Kariisa, Nana Wilson, Grant Baldwin. MMWR Morb Mortal Wkly Rep 2018
7

Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial.
Jane M Liebschutz, Denise Crooks, Debra Herman, Bradley Anderson, Judith Tsui, Lidia Z Meshesha, Shernaz Dossabhoy, Michael Stein. JAMA Intern Med 2014
195
7

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2009
851
7

Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study.
Lindsay A Pearce, Jeong Eun Min, Micah Piske, Haoxuan Zhou, Fahmida Homayra, Amanda Slaunwhite, Mike Irvine, Gina McGowan, Bohdan Nosyk. BMJ 2020
59
11

Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
Bobbi Jo H Yarborough, Scott P Stumbo, Dennis McCarty, Jennifer Mertens, Constance Weisner, Carla A Green. Drug Alcohol Depend 2016
72
9

Management of opioid use disorders: a national clinical practice guideline.
Julie Bruneau, Keith Ahamad, Marie-Ève Goyer, Ginette Poulin, Peter Selby, Benedikt Fischer, T Cameron Wild, Evan Wood. CMAJ 2018
184
7


Treatment utilization among persons with opioid use disorder in the United States.
Li-Tzy Wu, He Zhu, Marvin S Swartz. Drug Alcohol Depend 2016
197
7

Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
Gail D'Onofrio, Patrick G O'Connor, Michael V Pantalon, Marek C Chawarski, Susan H Busch, Patricia H Owens, Steven L Bernstein, David A Fiellin. JAMA 2015
464
6

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Barbara R Haight, Susan M Learned, Celine M Laffont, Paul J Fudala, Yue Zhao, Amanda S Garofalo, Mark K Greenwald, Vijay R Nadipelli, Walter Ling, Christian Heidbreder. Lancet 2019
112
6

Prevention and Treatment of Opioid Misuse and Addiction: A Review.
Nora D Volkow, Emily B Jones, Emily B Einstein, Eric M Wargo. JAMA Psychiatry 2019
227
6

Medication Treatment of Opioid Use Disorder.
James Bell, John Strang. Biol Psychiatry 2020
76
7

Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis.
Jun Ma, Yan-Ping Bao, Ru-Jia Wang, Meng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, Louisa Degenhardt, Michael Farrell, Frederic C Blow, Mark Ilgen,[...]. Mol Psychiatry 2019
117
6

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
Yih-Ing Hser, Elizabeth Evans, David Huang, Robert Weiss, Andrew Saxon, Kathleen M Carroll, George Woody, David Liu, Paul Wakim, Abigail G Matthews,[...]. Addiction 2016
113
6

Medication Treatment For Opioid Use Disorders In Substance Use Treatment Facilities.
Ramin Mojtabai, Christine Mauro, Melanie M Wall, Colleen L Barry, Mark Olfson. Health Aff (Millwood) 2019
89
6

Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.
Noa Krawczyk, Ramin Mojtabai, Elizabeth A Stuart, Michael Fingerhood, Deborah Agus, B Casey Lyons, Jonathan P Weiner, Brendan Saloner. Addiction 2020
43
13

Update on Barriers to Pharmacotherapy for Opioid Use Disorders.
Anjalee Sharma, Sharon M Kelly, Shannon Gwin Mitchell, Jan Gryczynski, Kevin E O'Grady, Robert P Schwartz. Curr Psychiatry Rep 2017
85
7


Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
Brandon S Bentzley, Kelly S Barth, Sudie E Back, Sarah W Book. J Subst Abuse Treat 2015
77
7

Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Roger A Rosenblatt, C Holly A Andrilla, Mary Catlin, Eric H Larson. Ann Fam Med 2015
244
6

The PHQ-9: validity of a brief depression severity measure.
K Kroenke, R L Spitzer, J B Williams. J Gen Intern Med 2001
6

National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment.
Christopher M Jones, Melinda Campopiano, Grant Baldwin, Elinore McCance-Katz. Am J Public Health 2015
442
6


Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.
Andrew S Huhn, J Gregory Hobelmann, Justin C Strickland, George A Oyler, Cecilia L Bergeria, Annie Umbricht, Kelly E Dunn. JAMA Netw Open 2020
30
20

Who stays in medication treatment for opioid use disorder? A national study of outpatient specialty treatment settings.
Noa Krawczyk, Arthur Robin Williams, Brendan Saloner, Magdalena Cerdá. J Subst Abuse Treat 2021
17
35

Meta-analysis of drug-related deaths soon after release from prison.
Elizabeth L C Merrall, Azar Kariminia, Ingrid A Binswanger, Michael S Hobbs, Michael Farrell, John Marsden, Sharon J Hutchinson, Sheila M Bird. Addiction 2010
381
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.